Navigation Links
Scientists reveal molecular secrets of the malaria parasite

In an innovative project with implications for malaria vaccine development, scientists have used genomics, proteomics and gene expression studies to trace how malaria parasites evolve on a molecular level as they move between their hosts and insect vectors. That focus on the parasites' complex life cycle is helping researchers understand when different genes switch on and off as the pathogens metamorphose through seven different life stages. In turn, that molecular-level data may benefit biomedical scientists who are identifying new targets for vaccines that would impede the parasite during stages when it is particularly vulnerable to intervention.

"We hope this project will help vaccine researchers find the best targets against malaria," says scientist Neil Hall, the first author of the paper that appears in the January 7th issue of Science. "The study's findings will help scientists identify parasite genes that are interacting with the host as well as new gene targets for vaccines that aim to prevent parasite transmission in the mosquito." The study highlights the genes in four malarial species that evolve rapidly because of "selective pressures" in the stages of their life cycles in their mosquito vectors and in their mammalian hosts. Malaria parasites undergo three stages in their mosquito vectors, three stages in their vertebrate hosts and a sexual development stage during which the parasite is transmitted between vector and host. The Science paper represents the culmination of four years of cooperative work by scientists at several research institutes, including: the Wellcome Trust Sanger Institute in the U.K., where the sequencing and genome annotation was performed on two species of rodent malaria (Plasmodium chabaudi and P. berghei); the University of Leiden in the Netherlands and Imperial College in England, where scientists carried out gene expression studies; and The Institute for Genomic Research (TIGR), in Maryland, where scientists did a compa
'"/>

Source:Eurekalert


Page: 1 2 3

Related biology news :

1. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
2. Scientists Replicate Hepatitis C Virus in Laboratory
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Scientists find missing enzyme for tuberculosis iron scavenging pathway
5. Scientists seek answers on what activates deadly anthrax spores
6. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
7. Scientists collaborate to assess health of global environment
8. Scientists decipher genome of fungus that can cause life-threatening infections
9. Scientists discover the cellular roots of graying hair
10. Scientists rid stem cell culture of key animal cells
11. Scientists develop new color-coded test for protein folding

Post Your Comments:
(Date:11/20/2009)...entific and technological frontiers. The National ...hat totals nearly $4.3 million for the diverse eff...ican Recovery and Reinvestment Act of 2009. , ...stigation of solar phenomena. Philip R. Goode, dis...capabilities of NJIT,s Big Bear Solar Observatory ...
(Date:11/20/2009)...about the health benefits of having a life partner...here amino acids known as cysteines are much more ...up with other cysteines. , Now, researchers at t...n Belgium, have discovered a new antioxidant syste...ears in the Nov. 20 issue of the journal Science ...
(Date:11/20/2009)...ahoma researchers were sequencing the first human ...Today, the OU Advanced Center for Genome Technolog...quence the tomato genome with a $7.5 million grant...ant genomics. , "The tomato has tremendous agri...op yields will improve quality of life," said Bruc...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Saving the single cysteine: New antioxidant system found 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2PTC Therapeutics Receives 242 6 Million in Government Grants 12621 1PTC Therapeutics Receives 242 6 Million in Government Grants 12621 2PTC Therapeutics Receives 242 6 Million in Government Grants 12621 3PTC Therapeutics Receives 242 6 Million in Government Grants 12621 4Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 1Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 2Proteolix Inc Drug Candidate PR 957 Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome 4591 3Top Performing Medical Equipment Companies Announced 48860 1Top Performing Medical Equipment Companies Announced 48860 2
...ns, Inc. (NYSE: ID ), a leading provider of ident...t closed its tender offer for all of the,outstandi... and completed its,acquisition of Digimarc,s ID sy... period for the tender offer expired at,5:00 p.m. ...ubsequent,offering period, L-1 purchased 22,093,16...
...ncers are inherited, but the genetic cause of most...colorectal cancer account for less than 5 percent ...sity,s Feinberg School of Medicine and colleagues ... 10 to 20 percent of patients with colorectal canc...s a major contributor to colorectal cancer risk an...
... response to daily stress is the focus of a study ... of control. , "Research shows that two-thirds o...despite the best efforts of their doctors. That is...of the Georgia Prevention Institute at the Medical... the mechanisms through which blood pressure is re...
Other Biology News:L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation 2L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation 3Scientists discover major genetic cause of colorectal cancer 2Blood pressure response to daily stress provides clues for better hypertension treatment 2Blood pressure response to daily stress provides clues for better hypertension treatment 3Blood pressure response to daily stress provides clues for better hypertension treatment 4Blood pressure response to daily stress provides clues for better hypertension treatment 5Blood pressure response to daily stress provides clues for better hypertension treatment 6
(Date:11/20/2009)...-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasd...ircuit Court of Appeals reversed a U.S. District C... pursue all of its claims against The Lash Group, ...ial. CTI filed a complaint against The Lash Group...t for CTI,s product TRISENOX, in 2007 seeking $22....
(Date:11/19/2009)...stCall/ -- Omeros Corporation (Nasdaq: OMER ) tod...hird quarter ended September 30, 2009. For the thr...d a net loss of $3.9 million, or $1.34 per share, ...4 per share, for the same period in 2008. For the ...reported a net loss of $15.5 million, or $5.29 per...
(Date:11/19/2009)...ss., Nov. 19 Arlington Medical Res...leading driver of antibiotic selection in nosocomi...against gram-positive and gram-negative pathogens....socomial pneumonia, surveyed European physicians r...vide appropriate coverage against common pathogens...
(Date:11/19/2009)...d by latest award for revolutionary hearing aid. ...ber 16, 2009 -- Popular Science Magazine has named...m InSound Medical a winner of its coveted Best of ...p;   Chosen from thousands of entra...ng canal for up to four months while providing nat...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...s, but it happens every year twice, in fact, as I...night was no exception. , ,After four months of i....m. deadline this morning to turn the raw ingredie...ram for 500-plus of DEMOs closest friends the inv...the event each year. , ,I dont go into the DEMO pr...
...has become is the first seed lab in the United Sta...ed Lab (ASL) program, administered by the United ...ny reported Tuesday. , , BioDiagnostics provides ...rvices. , ,The ASL Program is a voluntary, user-f... Seed testing laboratories, which meet all require...
...urer of diode lasers for industrial, defense, and ... $7 million in expansion funding, the company repo...d by GF Private Equity Group, LLC and included all...include ARCH Venture Partners, Advanced Technology...ture Investors, Wisconsin Alumni Research Foundati...
Other Biology Technology:DEMOfall - A return to simplicity 2DEMOfall - A return to simplicity 3Alfalight receives $7 million in expansion funding 2
Fluoroskan Ascent FL, 100-240 V from Thermo Scientific
Rabbit Anti-CHIP Polyclonal Antibody, Unconjugated from Abcam
Universal Adjustable Angle Test Tube Holder from Thermo Scientific
... Science, which pioneered the blending of thermost... and Expand Long Template PCR Systems, now introdu...irst product of a family of next-generation PCR Bl...with a novel proofreading protein isolated and cha...
Biology Products: